Salvatore De Vita

Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European community

Claudio Vitali, Stefano Bombardieri, Haralampos Μ. Moutsopoulos et al. · Arthritis & Rheumatism · 1993 · 1.4K citations

Medicine, Internal Medicine, Dermatopathology +13

EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies

Manuel Ramos‐Casals, Pilar Brito‐Zerón, Stefano Bombardieri et al. · Annals of the Rheumatic Diseases · 2019 · 695 citations · Full text

Medicine, Dermatology, Internal Medicine +16

Efficacy and safety of rituximab in type II mixed cryoglobulinemia

Francesco Zaja, Salvatore De Vita, Cesare Mazzaro et al. · Blood · 2003 · 490 citations · Full text

Medicine, Immunology, Internal Medicine +4

A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis

Salvatore De Vita, Luca Quartuccio, Miriam Isola et al. · Arthritis & Rheumatism · 2011 · 399 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15

Efficacy and safety of belimumab in primary Sjögren’s syndrome: results of the BELISS open-label phase II study

Xavier Mariette, Raphaèle Séror, Luca Quartuccio et al. · Annals of the Rheumatic Diseases · 2013 · 320 citations

Life Sciences, Immunology, Internal Medicine +17